Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) occupies a unique niche within the healthcare sector as a pioneering biotechnology firm dedicated to developing gene therapies for rare and severe diseases. With a..
Castle Biosciences, Inc. (NASDAQ: CSTL), headquartered in Friendswood, Texas, is a pioneering molecular diagnostics company that has carved a niche in the healthcare sector with its innovative test solutions for..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands out in the biotechnology sector, capturing investor interest with a potential upside of 61.91%. As a clinical-stage pharmaceutical company, Amylyx is focused on developing..
AxoGen, Inc. (NASDAQ: AXGN) is a key player in the healthcare sector, focusing on the development and commercialization of innovative technologies for peripheral nerve regeneration and repair. Headquartered in Alachua,..
SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector specializing in medical devices, is drawing investor interest with its innovative solutions addressing musculoskeletal disorders. Despite reporting financial metrics..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a promising name in the biotechnology sector, focusing on therapies for central nervous system disorders. This Boston-based clinical-stage biopharmaceutical company has captured investor..
For investors seeking opportunities in the ever-evolving healthcare sector, Geron Corporation (NASDAQ: GERN) presents an intriguing proposition. As a biotechnology company focused on oncology therapeutics, Geron has carved out a..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is attracting attention within the biotechnology sector, primarily due to its innovative pipeline and substantial market potential. With a market capitalization..
In the dynamic world of biotechnology, Trevi Therapeutics, Inc. (NASDAQ: TRVI) is gaining attention from investors with its ambitious clinical trials and promising market outlook. Specializing in treatments for chronic..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to drug discovery, particularly in targeted oncology and genetic disease..
For investors seeking a promising opportunity in the biotechnology sector, Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a compelling case with a potential upside of 42.63%. With its current stock price..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is capturing investor attention with a remarkable potential upside of 183.41% as reflected in its current analyst ratings. The company’s focus on innovative therapies for..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is capturing investor attention with its innovative solutions and notable potential..
Investors with an eye on the healthcare sector may find CareDx, Inc. (NASDAQ: CDNA) a compelling prospect. Specializing in diagnostic solutions for transplant patients, CareDx is operating within the ever-evolving..
As the cannabis industry continues to evolve and mature, Tilray Brands, Inc. (NASDAQ: TLRY) stands as a prominent player navigating the complex global landscape of medical and recreational cannabis products...
Kura Oncology, Inc. (NASDAQ: KURA) is making waves within the biotechnology sector, capturing investor attention with its promising pipeline and compelling upside potential. With a market capitalization of $962.41 million,..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing the attention of investors with its significant upside potential in the biotechnology sector. This clinical-stage biopharmaceutical company, based in Newtown Square, Pennsylvania, focuses..
Niagen Bioscience, Inc. (NAGE), a burgeoning player in the biotechnology sector, has recently captured the attention of investors with its substantial growth prospects. Based in the United States and trading..
Mind Medicine (MindMed) Inc. (MNMD) is capturing the attention of investors with its impressive potential upside of 113.45%, according to recent analyst ratings. As a pioneering force in the biotechnology..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to targeting G protein-coupled receptors (GPCRs). Headquartered in Watertown, Massachusetts,..
